Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

A. Gézsi, U. Budde, I. Deák, E. Nagy, A. Mohl, Á Schlammadinger, Z. Boda, T. Masszi, J. E. Sadler, I. Bodó

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background: von Willebrand disease (VWD) Vicenza is characterized by low plasma von Willebrand factor (VWF) levels, the presence of ultra-large (UL) VWF multimers and less prominent satellite bands on multimer gels, and the heterozygous amino acid substitution R1205H in the VWF gene. The pathogenesis of VWD Vicenza has been elusive. Accelerated clearance is implicated as a cause of low VWF level. Objectives: We addressed the question, whether the presence of ultra-large multimers is a cause, or a result of accelerated VWF clearance, or whether it is an unrelated phenomenon. Patients/methods: We studied the detailed phenotype of three Hungarian patients with VWD Vicenza, expressed the mutant VWF-R1205H in 293T cells and developed a mathematical model to simulate VWF synthesis and catabolism. Results: We found that the half-life of VWF after DDAVP was approximately one-tenth of that after the administration of Haemate P, a source of exogenous wild-type (WT) VWF (0.81 ± 0.2 vs. 7.25 ± 2.38 h). An analysis of recombinant mutant VWF-R1205H showed that the biosynthesis and multimer structure of WT and mutant VWF were indistinguishable. A mathematical model of the complex interplay of VWF synthesis, clearance and cleavage showed that decreasing VWF half-life to one-tenth of normal reproduced all features of VWD Vicenza including low VWF level, ultra-large multimers and a decrease of satellite band intensity. Conclusion: We conclude that accelerated clearance alone may explain all features of VWD Vicenza.

Original languageEnglish
Pages (from-to)1273-1280
Number of pages8
JournalJournal of Thrombosis and Haemostasis
Volume8
Issue number6
DOIs
Publication statusPublished - Jun 2010

Fingerprint

von Willebrand Diseases
von Willebrand Factor
Half-Life
Theoretical Models
Deamino Arginine Vasopressin
HEK293 Cells
Amino Acid Substitution

Keywords

  • Clearance
  • Von Willebrand disease
  • Von Willebrand factor

ASJC Scopus subject areas

  • Hematology

Cite this

Gézsi, A., Budde, U., Deák, I., Nagy, E., Mohl, A., Schlammadinger, Á., ... Bodó, I. (2010). Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza. Journal of Thrombosis and Haemostasis, 8(6), 1273-1280. https://doi.org/10.1111/j.1538-7836.2010.03753.x

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza. / Gézsi, A.; Budde, U.; Deák, I.; Nagy, E.; Mohl, A.; Schlammadinger, Á; Boda, Z.; Masszi, T.; Sadler, J. E.; Bodó, I.

In: Journal of Thrombosis and Haemostasis, Vol. 8, No. 6, 06.2010, p. 1273-1280.

Research output: Contribution to journalArticle

Gézsi, A, Budde, U, Deák, I, Nagy, E, Mohl, A, Schlammadinger, Á, Boda, Z, Masszi, T, Sadler, JE & Bodó, I 2010, 'Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza', Journal of Thrombosis and Haemostasis, vol. 8, no. 6, pp. 1273-1280. https://doi.org/10.1111/j.1538-7836.2010.03753.x
Gézsi, A. ; Budde, U. ; Deák, I. ; Nagy, E. ; Mohl, A. ; Schlammadinger, Á ; Boda, Z. ; Masszi, T. ; Sadler, J. E. ; Bodó, I. / Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza. In: Journal of Thrombosis and Haemostasis. 2010 ; Vol. 8, No. 6. pp. 1273-1280.
@article{685cee13f1554f16a062647a7bfe8e06,
title = "Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza",
abstract = "Background: von Willebrand disease (VWD) Vicenza is characterized by low plasma von Willebrand factor (VWF) levels, the presence of ultra-large (UL) VWF multimers and less prominent satellite bands on multimer gels, and the heterozygous amino acid substitution R1205H in the VWF gene. The pathogenesis of VWD Vicenza has been elusive. Accelerated clearance is implicated as a cause of low VWF level. Objectives: We addressed the question, whether the presence of ultra-large multimers is a cause, or a result of accelerated VWF clearance, or whether it is an unrelated phenomenon. Patients/methods: We studied the detailed phenotype of three Hungarian patients with VWD Vicenza, expressed the mutant VWF-R1205H in 293T cells and developed a mathematical model to simulate VWF synthesis and catabolism. Results: We found that the half-life of VWF after DDAVP was approximately one-tenth of that after the administration of Haemate P, a source of exogenous wild-type (WT) VWF (0.81 ± 0.2 vs. 7.25 ± 2.38 h). An analysis of recombinant mutant VWF-R1205H showed that the biosynthesis and multimer structure of WT and mutant VWF were indistinguishable. A mathematical model of the complex interplay of VWF synthesis, clearance and cleavage showed that decreasing VWF half-life to one-tenth of normal reproduced all features of VWD Vicenza including low VWF level, ultra-large multimers and a decrease of satellite band intensity. Conclusion: We conclude that accelerated clearance alone may explain all features of VWD Vicenza.",
keywords = "Clearance, Von Willebrand disease, Von Willebrand factor",
author = "A. G{\'e}zsi and U. Budde and I. De{\'a}k and E. Nagy and A. Mohl and {\'A} Schlammadinger and Z. Boda and T. Masszi and Sadler, {J. E.} and I. Bod{\'o}",
year = "2010",
month = "6",
doi = "10.1111/j.1538-7836.2010.03753.x",
language = "English",
volume = "8",
pages = "1273--1280",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

AU - Gézsi, A.

AU - Budde, U.

AU - Deák, I.

AU - Nagy, E.

AU - Mohl, A.

AU - Schlammadinger, Á

AU - Boda, Z.

AU - Masszi, T.

AU - Sadler, J. E.

AU - Bodó, I.

PY - 2010/6

Y1 - 2010/6

N2 - Background: von Willebrand disease (VWD) Vicenza is characterized by low plasma von Willebrand factor (VWF) levels, the presence of ultra-large (UL) VWF multimers and less prominent satellite bands on multimer gels, and the heterozygous amino acid substitution R1205H in the VWF gene. The pathogenesis of VWD Vicenza has been elusive. Accelerated clearance is implicated as a cause of low VWF level. Objectives: We addressed the question, whether the presence of ultra-large multimers is a cause, or a result of accelerated VWF clearance, or whether it is an unrelated phenomenon. Patients/methods: We studied the detailed phenotype of three Hungarian patients with VWD Vicenza, expressed the mutant VWF-R1205H in 293T cells and developed a mathematical model to simulate VWF synthesis and catabolism. Results: We found that the half-life of VWF after DDAVP was approximately one-tenth of that after the administration of Haemate P, a source of exogenous wild-type (WT) VWF (0.81 ± 0.2 vs. 7.25 ± 2.38 h). An analysis of recombinant mutant VWF-R1205H showed that the biosynthesis and multimer structure of WT and mutant VWF were indistinguishable. A mathematical model of the complex interplay of VWF synthesis, clearance and cleavage showed that decreasing VWF half-life to one-tenth of normal reproduced all features of VWD Vicenza including low VWF level, ultra-large multimers and a decrease of satellite band intensity. Conclusion: We conclude that accelerated clearance alone may explain all features of VWD Vicenza.

AB - Background: von Willebrand disease (VWD) Vicenza is characterized by low plasma von Willebrand factor (VWF) levels, the presence of ultra-large (UL) VWF multimers and less prominent satellite bands on multimer gels, and the heterozygous amino acid substitution R1205H in the VWF gene. The pathogenesis of VWD Vicenza has been elusive. Accelerated clearance is implicated as a cause of low VWF level. Objectives: We addressed the question, whether the presence of ultra-large multimers is a cause, or a result of accelerated VWF clearance, or whether it is an unrelated phenomenon. Patients/methods: We studied the detailed phenotype of three Hungarian patients with VWD Vicenza, expressed the mutant VWF-R1205H in 293T cells and developed a mathematical model to simulate VWF synthesis and catabolism. Results: We found that the half-life of VWF after DDAVP was approximately one-tenth of that after the administration of Haemate P, a source of exogenous wild-type (WT) VWF (0.81 ± 0.2 vs. 7.25 ± 2.38 h). An analysis of recombinant mutant VWF-R1205H showed that the biosynthesis and multimer structure of WT and mutant VWF were indistinguishable. A mathematical model of the complex interplay of VWF synthesis, clearance and cleavage showed that decreasing VWF half-life to one-tenth of normal reproduced all features of VWD Vicenza including low VWF level, ultra-large multimers and a decrease of satellite band intensity. Conclusion: We conclude that accelerated clearance alone may explain all features of VWD Vicenza.

KW - Clearance

KW - Von Willebrand disease

KW - Von Willebrand factor

UR - http://www.scopus.com/inward/record.url?scp=77954466579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954466579&partnerID=8YFLogxK

U2 - 10.1111/j.1538-7836.2010.03753.x

DO - 10.1111/j.1538-7836.2010.03753.x

M3 - Article

VL - 8

SP - 1273

EP - 1280

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 6

ER -